Industry Insights

  1. Getting Executive Backing For A Digital QMS 8/26/2021

    This article offers guidance that will help you quantify and communicate the importance of quality, and how a digital QMS delivers considerable savings.

  2. TMT Labeling For Optimized Sample Preparation In Quantitative Proteomics 5/13/2025

    Leverage the power of Tandem Mass Tags (TMT) quantitative proteomics to gain deep insights into cellular dynamics, disease mechanisms, and drug targeting.

  3. The Case For Early Use Of cGMP Raw Materials 7/14/2023

    Using cGMP grade reagents earlier makes for a seamless transition while maintaining quality and viability.

  4. Cell Culture Media Analysis For Gene Therapy 1/13/2022

    Efficient viral vector production is a key element for gene therapy manufacturing where improving overall yield is still the biggest hurdle.

  5. A Multi-Attribute Analysis CE Platform Assesses Identity And Titer Of LVVs 3/13/2023

    As lentiviral vectors become more attractive options for CGT applications, sponsors need robust, efficient analytical platforms to accommodate upstream and downstream assessment.

  6. Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°C

    This study worked to determine if the chosen vial-stopper-seal combination will remain integral while frozen at -80°C, under studied conditions, when the appropriate materials, processing, and sealing conditions are applied.

  7. Ready To Amplify Plasmid (pDNA) In Bacteria? 11/14/2023

    Explore how to use and amplify pDNA from the development of recombinant proteins and viral vectors to advanced bio-therapeutics such as mRNA vaccines.

  8. Innovations In Peptide Manufacturing 1/23/2025

    The peptide manufacturing industry is evolving to meet the demands of efficiency, scalability, and sustainability. Learn how the latest innovations are addressing these challenges.

  9. Partnering At Every Stage: Providing Capable Capacity For Manufacturing

    Finding a CDMO partner with the requisite expertise, materials, external supply chain, and capacity is key to maximizing a therapy’s chances of commercial success.

  10. Solid Tumors: The Next Frontier Of Cancer Immunotherapy 2/14/2024

    With the use of advanced in vitro models like Organ-Chips, researchers are gaining a better understanding of CAR T-cell therapy in the context of solid tumors.